• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

MD Anderson Kicks Off Apple Watch Pilot for Breast Cancer Patients

by HITC Staff 12/03/2015 Leave a Comment

MD Anderson Kicks Off Apple Watch Pilot for Breast Cancer Patients

Back in May, MD Anderson Cancer Center at Cooper announced it was teaming up with behavioral health technology company Polaris Health Directions (Polaris) on an behavioral health pilot project using the Apple Watch to help improve breast cancer treatment outcomes. This week, the pilot project officially kicked off reaching patient hands (wrists) for the first time via the Apple Watch. 

The partnership brings together MD Anderson Cooper’s expertise in oncology and Polaris’s deep experience in behavioral health science and innovative technology. It will leverage Polaris’s Polestar behavioral health outcomes management (BHOM) platform–an advanced data-collection-and-analytics platform that provides meaningful, actionable results for reporting on and monitoring of a patient’s expected treatment response.

Apple Watch Breast Cancer Pilot Details

Patients taking part in the nine month-long study each receive a customized Apple Watch and will use Polaris’s emPOWER app to record their experiences during specific times in their treatment cycle. Through emPOWER, patients will gain insights into changes in their mindset as they progress through treatment. They can also use the app to connect to other cancer patients, and reach out in real-time to their care team and other members of their patient cohort for both clinical and social support. 

The emPOWER app monitors patients’ behavioral health data such as treatment side effects, sleep information, physical activity levels, patient mood and other measurable information captured through the Apple Watch. By collecting and analyzing pertinent behavioral health data, one of the app’s central goals is to improve quality of life for cancer patients. The app leverages Apple’s robust iOS HealthKit API to access relevant patient physical health metrics that are used in correlation with the data collected via emPOWER to improve patient outcomes. 

Adjustments to lifestyle changes and uncertainty are among the most significant challenges facing cancer patients. “I think a huge piece of addressing the uncertainty felt by cancer patients is advancing their health literacy. When patients are able to monitor their own behaviors, they are able to better understand the correlations between those behaviors and how they are feeling, and even change those behaviors to improve their quality of life,” said Cori McMahon, PsyD, director of Behavioral Medicine at MD Anderson at Cooper. 

Tagged With: Apple Watch, MD Anderson, Wearable Pilots

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |